.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Federal Trade Commission
Cerilliant
Farmers Insurance
Express Scripts
Fish and Richardson
Harvard Business School
Merck
Queensland Health

Generated: December 17, 2017

DrugPatentWatch Database Preview

Amcinonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amcinonide and what is the scope of amcinonide patent protection?

Amcinonide
is the generic ingredient in two branded drugs marketed by Fougera Pharms, Taro Pharm Inds, and Astellas, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for amcinonide. Two suppliers are listed for this compound.

Summary for amcinonide

Pharmacology for amcinonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AstellasCYCLOCORTamcinonideOINTMENT;TOPICAL018498-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
AstellasCYCLOCORTamcinonideLOTION;TOPICAL019729-001Jun 13, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe
Fougera PharmsAMCINONIDEamcinonideOINTMENT;TOPICAL076096-001Nov 19, 2002ABRXNoYes► Subscribe► Subscribe► Subscribe
Fougera PharmsAMCINONIDEamcinonideLOTION;TOPICAL076329-001Nov 6, 2002RXNoYes► Subscribe► Subscribe► Subscribe
Taro Pharm IndsAMCINONIDEamcinonideCREAM;TOPICAL076229-001May 31, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
AstellasCYCLOCORTamcinonideCREAM;TOPICAL018116-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Fougera PharmsAMCINONIDEamcinonideCREAM;TOPICAL076065-001May 15, 2003ABRXNoYes► Subscribe► Subscribe► Subscribe
AstellasCYCLOCORTamcinonideCREAM;TOPICAL018116-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Taro Pharm IndsAMCINONIDEamcinonideOINTMENT;TOPICAL076367-001Mar 19, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: amcinonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AstellasCYCLOCORTamcinonideCREAM;TOPICAL018116-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
AstellasCYCLOCORTamcinonideOINTMENT;TOPICAL018498-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Colorcon
Argus Health
Dow
AstraZeneca
Farmers Insurance
Medtronic
Novartis
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot